Roche to challenge Pfizer with drug to enhance "good" cholesterol

10/21/2004 | Reuters

Roche Holding is challenging Pfizer in the effort to develop a drug focusing on the "good" type of cholesterol by licensing the JTT-705 experimental drug from Japan Tobacco. Pfizer's version is further along in the clinical-trial stage, but Roche plans to use the Japanese product to compete with Pfizer in the market for a cholesteryl ester transfer protein inhibitor.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY